In Memoriam: Rachna Shroff, MD, MS, FASCO: A Life Dedicated to Advancing Cancer Care
RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy
Advanced Bladder Cancer: How Is First-Line Treatment Changing?
NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer
IARC Director Elisabete Weiderpass to Discuss How to Turn Cancer Research Into Action at Momentum 2026
Secure Your Place at the European Cancer Summit and Help Shape the Future of Cancer Research - ECO
Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care
Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts
